Insulin-like growth factor 2 (IGF2) emerged as a critical mechanism of synaptic plasticity and
learning and memory. Deficits in IGF2 in the brain, serum, or cerebrospinal fluid (CSF) are …

A number of studies performed on rodents suggest that insulin-like growth factor 2 (IGF-2) or
its analogs may possibly be used for treating some conditions like Alzheimer's disease …

Abnormal N-methyl-d-aspartate receptor (NMDAR) function has been implicated in the
pathophysiology of schizophrenia. d-serine is an important NMDAR modulator, and to …

Objective: To evaluate the effects of 20 weeks of resistance and concurrent training on
psychotic and depressive symptoms, quality of life outcomes, and serum IGF-1, IGFBP-3 …

Insulin-like growth factor 2 (IGF2) is abundantly expressed in the central nervous system
(CNS). Recent evidence highlights the role of IGF2 in the brain, sustained by data showing …

The association between schizophrenia (SZ) and uric acid (UA) levels has been suggested
for many years, but without solid evidence. Therefore, we conducted a systematic review …

The Insulin-like growth factor 2 (IGF-2) has been recently proven to alleviate depressive-like
behaviors in both rats and mice models. However, its potential role as a peripheral …

Background Schizophrenia is linked with abnormal brain neurodevelopment, on which IGF-
2 (insulin-like growth factor-2) has a great impact. The purpose of this study was to assess …

Insulin-like growth factor 2 (IGF-2) and IGF binding protein 7 (IGFBP-7) have been related to
schizophrenia (SZ) due to their implication in neurodevelopment. The purpose of this study …

The concept of metabolic syndrome in psychiatry provides a united front for confronting a
series of metabolic changes that are predictive of cardiovascular disease (CVD) and type 2 …